Renal safety profile of tyrosine kinase inhibitors targeting BCR-ABL: A study from VigiBase (R), the WHO global database of individual case safety reports

M. Cellier, D. Bourneau-Martin, A. Crosnier, G. Drablier,L. Lagarce,M. Briet

FUNDAMENTAL & CLINICAL PHARMACOLOGY(2022)

引用 0|浏览5
暂无评分
关键词
tyrosine kinase inhibitor, renal safety, nephrotic syndrome, renal artery stenosis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要